{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["cancer patients", "clinical trials", "herbal drug", "herbal medicine", "integrative medicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38099482", "DateCompleted": {"Year": "2023", "Month": "12", "Day": "16"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "18"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["15347354231218255", "10.1177/15347354231218255"], "Journal": {"ISSN": "1552-695X", "JournalIssue": {"Volume": "22", "PubDate": {"Year": "2023", "Season": "Jan-Dec"}}, "Title": "Integrative cancer therapies", "ISOAbbreviation": "Integr Cancer Ther"}, "ArticleTitle": "Current Characteristics of Herbal Medicine Interventions for Cancer on Clinical Databases: A Cross-Sectional Study.", "Pagination": {"StartPage": "15347354231218255", "MedlinePgn": "15347354231218255"}, "Abstract": {"AbstractText": ["The utilization of herbal medicine has been noteworthy for treating cancer; however, there is not enough information regarding the characteristics of clinical trials of herbal medicine interventions. This study aimed to evaluate the characteristic of registered trials using herbal medicine interventions for cancer.", "A cross-sectional study was performed via the website ClinicalTrials.gov, ISRCTN registry, Chinese clinical trial registry, and international clinical trials registry platform to gather associated registered clinical trials using an advanced search with the developed keyword strategy as of March 26, 2023. All obtainable information from the trials was collected without any restrictions to conduct a comprehensive review.", "A total of 169 registered trials were included for evaluation. Of all trials, 102 trials were eligible for this study. Countries from Asia registered the most trials (62.75%), and hospitals sponsored most of the trials (42.16%). Randomized, Phase 2, interventional trials were dominant, and approximately 64.71% of the trials anticipated recruiting less than 100 participants. More than half of the trials were from 2016 to 2023 (53.92%). While 45 trials were completed, only 16 trials had results for further analysis. According to the completed results, the types of herbal medicines from the trials mainly focused on lung, breast, and colorectal cancer.", "This study is the first to explore the characteristics of clinical trials of herbal medicine for cancer registered in large clinical databases. The acquired trials had relatively informative data; however, better-designed trials may be needed for health professionals to consider herbal medicine as an option when treating cancer patients."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hwasung Medi-Science University, Hwaseong-si, Gyeonggi-do, South Korea."}], "LastName": "Youn", "ForeName": "Bo-Young", "Initials": "BY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Kim", "ForeName": "Ji-Hyun", "Initials": "JH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Jo", "ForeName": "Yong-Kyu", "Initials": "YK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Yoon", "ForeName": "Sanghoon", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Im", "ForeName": "Ji-Yeong", "Initials": "JY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Kim", "ForeName": "Hyo-Jung", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Lee", "ForeName": "Jae-Dong", "Initials": "JD"}, {"Identifier": ["0000-0002-2345-430X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Ko", "ForeName": "Seong-Gyu", "Initials": "SG"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Integr Cancer Ther", "NlmUniqueID": "101128834", "ISSNLinking": "1534-7354"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Cross-Sectional Studies"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}], "CoiStatement": "Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Choudhari AS, Mandave PC, Deshpande M, Ranjekar P, Prakash O. Phytochemicals in cancer treatment: from preclinical studies to clinical practice. Front Pharmacol. 2019;10:1614-1630.", "ArticleIdList": ["PMC7025531", "32116665"]}, {"Citation": "Youn BY, Lee SY, Cho W, et al.. Global trends of nutrition in cancer research: A bibliometric and visualized analysis study over the past 10 years. Int J Environ Res Public Health. 2022;19:4165-4176.", "ArticleIdList": ["PMC8998574", "35409847"]}, {"Citation": "\nWorld Health Organization. Cancer key factors. Accessed December 2, 2022. https://www.who.int/news-room/fact-sheets/detail/cancer"}, {"Citation": "Poonthananiwatkul B, Howard RL, Williamson EM, Lim RH. Cancer patients taking herbal medicines: A review of clinical purposes, associated factors, and perceptions of benefit or harm. J Ethnopharmacol. 2015;175:58-66.", "ArticleIdList": ["26344852"]}, {"Citation": "\nWorld Health Organization.\nKey technical issues of herbal medicine with references to interactions with other medicines. Accessed December 3, 2022. https://www.who.int/publications/i/item/9789240019140"}, {"Citation": "Asiimwe JB, Nagendrappa PB, Atukunda EC, et al.. Prevalence of the use of herbal medicines among patients with cancer: A systematic review and meta-analysis. Evid Based Complement Alternat Med. 2021;2021:9963038-9963118.", "ArticleIdList": ["PMC8149249", "34055029"]}, {"Citation": "Theuser AK, Hack CC, Fasching PA, et al.. Patterns and trends of herbal medicine use among patients with gynecologic cancer. Geburtshilfe Frauenheilkd. 2021;81:699-707.", "ArticleIdList": ["PMC8216777", "34168382"]}, {"Citation": "Ying J, Zhang M, Qiu X, Lu Y. The potential of herb medicines in the treatment of esophageal cancer. Biomed Pharmacother. 2018;103:381-390.", "ArticleIdList": ["29674273"]}, {"Citation": "Aiello P, Sharghi M, Mansourkhani SM, et al.. Medicinal plants in the prevention and treatment of colon cancer. Ovix Med Cell Longev. 2019;2019:1-51.", "ArticleIdList": ["PMC7187726", "32377288"]}, {"Citation": "Lee YK, Bae K, Yoo HS, Cho SH. Benefit of adjuvant traditional herbal medicine with chemotherapy for resectable gastric cancer. Integr Cancer Ther. 2018;17:619-627.", "ArticleIdList": ["PMC6142080", "29614889"]}, {"Citation": "Jeong TY, Park BK, Cho JH, et al.. A prospective study on the safety of herbal medicines, used alone or with conventional medicines. J Ethnopharmacol. 2012;143:884-888.", "ArticleIdList": ["22940254"]}, {"Citation": "Glanville JM, Duffy S, McCool R, Varley D. Searching clinicaltrials.gov and the international clinical trials registry platform to inform systematic reviews: what are the optimal search approaches? J Med Libr Assoc. 2014;102:177-183.", "ArticleIdList": ["PMC4076126", "25031558"]}, {"Citation": "Zeng X, Zhang Y, Kwong JS, et al.. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: A systematic review. J Evid Based Med. 2015;8:2-10.", "ArticleIdList": ["25594108"]}, {"Citation": "Califf RM, Zarin DA, Kramer JM, et al.. Characteristics of clinical trials registered in clinicaltrials.gov, 2007-2010. JAMA. 2012;307:1838-1847.", "ArticleIdList": ["22550198"]}, {"Citation": "Hoimes CJ, Lamb L, Ruta S, et al.. A phase I/II study of PHY906 plus capecitabine (CAP) in patients (pts) with advanced pancreatic cancer (APC). J Clin Oncol. 2008;26(15_suppl):15538."}, {"Citation": "Lam W, Bussom S, Guan F, et al.. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity. Sci Transl Med. 2010;2(45):45ra59.", "ArticleIdList": ["20720216"]}, {"Citation": "Pang CLK, Zhang X, Wang Z, et al.. Local modulated electro-hyperthermia in combination with traditional Chinese medicine vs. Intraperitoneal chemoinfusion for the treatment of peritoneal carcinomatosis with malignant ascites: A phase II randomized trial. Mol Clin Oncol. 2017;6(5):723-732.", "ArticleIdList": ["PMC5431547", "28529748"]}, {"Citation": "Engels FK, de Jong FA, Sparreboom A, et al.. Medicinal cannabis does not influence the clinical pharmacokinetics of irinotecan and docetaxel. Oncologist. 2007;12(3):291-300.", "ArticleIdList": ["17405893"]}, {"Citation": "Jiang Y, Wu L, Shen L, et al.. Effect of traditional Chinese medicine treatment as maintenance therapy on regulating the serum concentration of sCTLA-4 in patients with advanced non-small-cell lung cancer and its relationship with prognosis. Zhonghua Zhong Liu Za Zhi. 2016;38(10):757-762.", "ArticleIdList": ["27784460"]}, {"Citation": "\nClinicalTrials.gov. A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma. Accessed July 29, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT00411762"}, {"Citation": "\nClinicalTrials.gov. Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream (AIJP). Accessed July 29, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT00622440"}, {"Citation": "Macaya A, Mu\u00f1oz-Santos C, Balaguer A, Barber\u00e0 MJ. Interventions for anal canal intraepithelial neoplasia. Cochrane Database Syst Rev. 2012;12:CD009244-NaN23.", "ArticleIdList": ["PMC6823263", "23235673"]}, {"Citation": "\nClinicalTrials.gov. A Phase II Multicenter, Randomized, Placebo Controlled, Double Blinded Clinical Study of KD018 as a Modulator of Irinotecan Chemotherapy in Patients With Metastatic Colorectal Cancer. Accessed July 29, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT00730158"}, {"Citation": "\nClinicalTrials.gov. Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT (OTMA-RII). Accessed July 29, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT02638051"}, {"Citation": "\nClinicalTrials.gov. Herbal Mouthrinse for Oral Mucositis Study (OM). Accessed July 29, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT01898091"}, {"Citation": "\nISRCTN Registry. Influence of Medicinal Cannabis (Bedrocan) on the Ppharmacokinetics of Irinotecan and Docetaxel in Cancer Patients. Accessed July 29, 2023. https://www.isrctn.com/ISRCTN72088851"}, {"Citation": "\nChinese Clinical Trial Registry. Randomized Controlled Clinical Study to Evaluate the Efficacy and Safety of Integrated Traditional Chinese Medicine Treatment as Maintenance Therapy for Patients with Advanced Non-small-cell Lung Cancer. Accessed July 29, 2023. https://www.chictr.org.cn/showprojEN.html?proj=8521"}, {"Citation": "Dorff TB, Tsao-Wei DD, Hawes D, et al.. Final results from a trial of a combination herbal supplement for biochemically recurrent prostate cancer. J Clin Oncol. 2013;31(15_suppl):316020."}, {"Citation": "Cheng CW, Mok HF, Yau CWS, et al.. A pilot randomized placebo-controlled study on modified MaZiRenWan: a formulated Chinese medicine to relieve constipation for palliative cancer patients. Chin Med. 2022;17(1):31.", "ArticleIdList": ["PMC8889635", "35236375"]}, {"Citation": "Cheon C, Yoo JE, Yoo HS, et al.. Efficacy and safety of Sipjeondaebo-Tang for anorexia in patients with cancer: A pilot, randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med. 2017;2017:8780325.", "ArticleIdList": ["PMC5758845", "29441116"]}, {"Citation": "Changou CA, Shiah HS, Chen LT, et al.. A phase II clinical trial on the combination therapy of PHY906 plus capecitabine in hepatocellular carcinoma. Oncologist. 2021;26(3):e367-e373.", "ArticleIdList": ["PMC7930412", "33140457"]}, {"Citation": "Xu Y, Wang XS, Chen Y, et al.. A phase II randomized controlled trial of Renshen Yangrong Tang herbal extract granules for fatigue reduction in cancer survivors. J Pain Symptom Manag. 2020;59(5):966-973.", "ArticleIdList": ["31668965"]}, {"Citation": "Wang Q, Jiao L, Wang S, et al.. Maintenance chemotherapy with Chinese herb medicine formulas vs. With placebo in patients with advanced non-small cell lung cancer after first-line chemotherapy: a multicenter, randomized, double-blind trial. Front Pharmacol. 2018;9:1233.", "ArticleIdList": ["PMC6232388", "30459612"]}, {"Citation": "Famil-Dardashti A, Hajigholami A, Badri S, Yekdaneh A, Moghaddas A. The role of trigonella, cichorium, and foeniculum herbal combination in the treatment of cancer-induced Anorexia/Cachexia: A quasi-experimental study. Int J Cancer Manag. 2020;13(8):e102515."}, {"Citation": "Yaghobi N, Mehrzad V, Badri S, Yegdaneh A, Moghaddas A. Combination of traditional herbal medicine for the treatment of cancer-induced Anorexia/Cachexia: A pilot, randomized, double-blinded and placebo-controlled clinical trial. J Herb Med. 2021;29:100499."}, {"Citation": "\nClinicalTrials.gov. Herbal Therapy for Treatment of Recurrent Prostate Cancer. Accessed August 23, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT00669656"}, {"Citation": "\nClinicalTrials.gov. Clinical Trial on Palliative Cancer Patients With Constipation. Accessed August 23, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT02795390"}, {"Citation": "\nClinicalTrials.gov. Effect of Sipjeondaebo-tang for Cancer Related Anorexia in Cancer Patients. Accessed August 23, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT02468141"}, {"Citation": "\nClinicalTrials.gov. Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma. Accessed August 23, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT00076609"}, {"Citation": "\nClinicalTrials.gov. RSYR for Fatigue Reduction in Cancer Survivors. Accessed August 23, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT03911921"}, {"Citation": "\nClinicalTrials.gov. Clinical Study of Chinese Medicine Plus Chemotherapy Maintenance in Advanced Non Small Cell Lung Cancer. Accessed August 23, 2023. https://classic.clinicaltrials.gov/ct2/show/NCT02900742"}, {"Citation": "\nInternational Clinical Trials Registry Platform. Trigonella, Foeniculum, Chichorium in prevention of cancer-induced cachexia/anorexia. Accessed August 23, 2023. https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT20180722040556N2"}, {"Citation": "\nInternational Clinical Trials Registry Platform. Trigonella, Foeniculum, Chichorium, Hornleum and Glycine in prevention of cancer-induced cachexia/anorexia. Accessed August 23, 2023. https://trialsearch.who.int/Trial2.aspx?TrialID=IRCT20180722040556N1"}, {"Citation": "\nPolaris Market Research. The global herbal medicine market size. Accessed December 9, 2022. https://www.polarismarketresearch.com/industry-analysis/herbal-medicine-market, 2020"}, {"Citation": "Colige A, Sokolov BP, Nugent P, Baserga R, Prockop DJ. Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells. Biochemistry. 1993;32:7-11.", "ArticleIdList": ["8418862"]}, {"Citation": "Yin SY, Wei WC, Jian FY, Yang NS. Therapeutic applications of herbal medicines for cancer patients. Evid Based Complement Alternat Med. 2013;2013:302426-302515.", "ArticleIdList": ["PMC3727181", "23956768"]}, {"Citation": "Nayeri ND, Bakhshi F, Khosravi A, Najafi Z. The effect of complementary and alternative medicines on quality of life in patients with breast cancer: a systematic review. Indian J Palliat Care. 2020;26:95-104.", "ArticleIdList": ["PMC7017686", "32132792"]}, {"Citation": "Yoon JH, Kim EH, Park SB, Lee JY, Yoon SW. Traditional herbal medicine for insomnia in patients with cancer: a systematic review and meta-analysis. Front Pharmacol. 2021;12:753140-753211.", "ArticleIdList": ["PMC8581246", "34776971"]}, {"Citation": "Henke O, Bruchhausen W, Massawe A. Use of herbal medicine is associated with late-stage presentation in Tanzanian patients with cancer: A survey to assess the utilization of and reasons for the use of herbal medicine. J Glob Oncol. 2022;8(8):e2200069-NaN8.", "ArticleIdList": ["PMC9296184", "35820080"]}, {"Citation": "Werneke U, Earl J, Seydel C, et al.. Potential health risks of complementary alternative medicines in cancer patients. Br J Cancer. 2004;90:408-413.", "ArticleIdList": ["PMC2410154", "14735185"]}, {"Citation": "L\u00fcthi E, Diezi M, Danon N, et al.. Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment. BMC Complement Med Ther. 2021;21:96-106.", "ArticleIdList": ["PMC7977159", "33736643"]}, {"Citation": "Ciarlo G, Ahmadi E, Welter S, H\u00fcbner J. Factors influencing the usage of complementary and alternative medicine by patients with cancer. Complement Ther Clin Pract. 2021;44:101389-101398.", "ArticleIdList": ["33932731"]}, {"Citation": "Bonucci M, Geraci A, Pero D, et al.. Complementary and integrative approaches to cancer: a pilot survey of attitudes and habits among cancer patients in Italy. Evid Based Complement Alternat Med. 2022;2022:1-10.", "ArticleIdList": ["PMC9359845", "35958921"]}, {"Citation": "Chen SL, Lin WC, Chen YC, et al.. The association between mortality and use of Chinese herbal medicine among incident stage IV esophageal cancer patients: A retrospective cohort study with core herbs exploration. Front Pharmacol. 2022;13:1018281-1018314.", "ArticleIdList": ["PMC9582778", "36278218"]}, {"Citation": "Hu XQ, Sun Y, Lau E, Zhao M, Su SB. Advances in synergistic combinations of Chinese herbal medicine for the treatment of cancer. Curr Cancer Drug Targets. 2016;16:346-356.", "ArticleIdList": ["PMC5425653", "26638885"]}, {"Citation": "Pak PJ, Lee DG, Sung JH, et al.. Synergistic effect of the herbal mixture C5E on gemcitabine treatment in PANC-1 cells. Mol Med Rep. 2021;23:346-356.", "ArticleIdList": ["PMC7974510", "33760105"]}, {"Citation": "Alsanad SM, Howard RL, Williamson EM. An assessment of the impact of herb-drug combinations used by cancer patients. BMC Complement Altern Med. 2016;16:393-401.", "ArticleIdList": ["PMC5070090", "27756298"]}, {"Citation": "Huang J, Li JX, Ma LR, et al.. Traditional herbal medicine: A potential therapeutic approach for adjuvant treatment of non-small cell lung cancer in the future. Integr Cancer Ther. 2022;21:15347354221144312-15347354221144313.", "ArticleIdList": ["PMC9806388", "36567455"]}, {"Citation": "Kocot-K\u0119pska M, Zaj\u0105czkowska R, Zhao J, et al.. The role of complementary and alternative methods in the treatment of pain in patients with cancer - current evidence and clinical practice: a narrative review. Contemp Oncol. 2021;25(2):88-94.", "ArticleIdList": ["PMC8506432", "34667434"]}, {"Citation": "Domnick M, Domnick M, Wiebelitz KR, Beer AM. Evaluation of the effectiveness of a multimodal complementary medicine program for improving the quality of life of cancer patients during adjuvant radiotherapy and/or chemotherapy or outpatient aftercare. Oncology. 2017;93(2):83-91.", "ArticleIdList": ["28472802"]}, {"Citation": "Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7-33.", "ArticleIdList": ["35020204"]}, {"Citation": "Lee K, Youn BY, Choi YJ, et al.. State of the art and future implications of SH003: acting as a therapeutic anticancer agent. Cancers. 2022;14(4):1089.", "ArticleIdList": ["PMC8870567", "35205836"]}, {"Citation": "Liu SH, Cheng YC. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol. 2012;140:614-623.", "ArticleIdList": ["22326673"]}, {"Citation": "Che CT, Wang ZJ, Chow MS, Lam CW. Herb-herb combination for therapeutic enhancement and advancement: theory, practice and future perspectives. Molecules. 2013;18:5125-5141.", "ArticleIdList": ["PMC6269890", "23644978"]}, {"Citation": "Tang S, Ren J, Kong L, et al.. Ephedrae herba: A review of its phytochemistry, pharmacology, clinical application, and alkaloid toxicity. Molecules. 2023;28(2):663.", "ArticleIdList": ["PMC9863261", "36677722"]}, {"Citation": "Lam CS, Koon HK, Ma CT, et al.. Real-world data on herb-drug interactions in oncology: a scoping review of pharmacoepidemiological studies. Phytomedicine. 2022;103:154247.", "ArticleIdList": ["35716539"]}, {"Citation": "Okem A, Henstra C, Lambert M, Hayeshi R. A review of the pharmacodynamic effect of chemo-herbal drug combinations therapy for cancer treatment. Med Drug Discov. 2023;17:100147."}, {"Citation": "Jo HG, Seo J, Choi S, Lee D. East Asian herbal medicine to reduce primary pain and adverse events in Cancer Patients : A systematic review and meta-analysis with association rule mining to identify core herb combination. Front Pharmacol. 2021;12:800571.", "ArticleIdList": ["PMC8802093", "35111066"]}, {"Citation": "Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evid Based Complement Alternat Med. 2015;2015:316706-316713.", "ArticleIdList": ["PMC4370194", "25838831"]}, {"Citation": "Parveen A, Parveen B, Parveen R, Ahmad S. Challenges and guidelines for clinical trial of herbal drugs. J Pharm Bioallied Sci. 2015;7:329-333.", "ArticleIdList": ["PMC4678978", "26681895"]}, {"Citation": "Li X, Qin Y, Liu W, et al.. Efficacy of Ginger in ameliorating acute and delayed chemotherapy-induced nausea and vomiting among patients with lung cancer receiving cisplatin-based regimens: a randomized controlled trial. Integr Cancer Ther. 2018;17(3):747-754.", "ArticleIdList": ["PMC6142108", "29417850"]}, {"Citation": "Barton DL, Liu H, Dakhil SR, et al.. Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013;105(16):1230-1238.", "ArticleIdList": ["PMC3888141", "23853057"]}, {"Citation": "Howells LM, Iwuji COO, Irving GRB, et al.. Curcumin combined with FOLFOX Chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIa Trial. J Nutr. 2019;149(7):1133-1139.", "ArticleIdList": ["PMC6602900", "31132111"]}, {"Citation": "Tr\u00f6ger W, Galun D, Reif M, et al.. Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial. Dtsch Arztebl Int. 2014;111(29-30):493-502.", "ArticleIdList": ["PMC4150026", "25142075"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "12", "Day": "17", "Hour": "17", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "15", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "15", "Hour": "5", "Minute": "42"}, {"Year": "2023", "Month": "12", "Day": "15"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38099482", "PMC10725141", "10.1177/15347354231218255"]}}], "PubmedBookArticle": []}